The article by Katharine Davis Fishman includes encouraging info on olaparib, an experimental targeted therapy for recurrent triple negative breast cancer. It also describes drugs and drug combinations being tested for stage 4 melanoma, which is currently wreaking havoc on my cousin Kurt and his family in Oregon.
Ms. Fishman’s article reinforces – to my mind – how important it is to familiarize yourself with the clinical trial landscape (and how to find the ones that match your situation) if you, or a loved one, are fighting a disease for which treatment options are limited.
Rock on, researchers. And Godspeed to the people in those trials.
If you can’t access the article, email me and I will send it to you.